Median Technologies

Type: Company

Name: Median Technologies

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

MEDIAN Technologies Awarded Phase II Oncology Trial in Asia

MEDIAN Technologies selected by Oxford Oncology to provide imaging solutions and services in a phase II clinical trial on lung cancer.MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image ... [Published Medicexchange.com - Apr 25 2013]

Entities: Median Technologies, Oncology, Phase II

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

MEDIAN Technologies selected as imaging solutions provider in phase II NSCLC clinical trial

MEDIAN Technologies (Paris:ALMDT) (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions ... [Published News-Medical.Net - Apr 22 2013]

Entities: Median Technologies, non-small cell lung cancer, Clinical trials, Phase II

First reported Mar 13 2013 - Updated Mar 13 2013 - 1 reports

MEDIAN Technologies Announces New €633,000 Study Award Business Wire

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)-- Regulatory News : MEDIAN Technologies (ALMDT.PA), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced ... [Published Yahoo! Finance - Mar 13 2013]

Entities: Median Technologies, Fredrik Brag, Clinical trials, Medical Imaging

First reported Mar 01 2013 - Updated Mar 01 2013 - 1 reports

MEDIAN Technologies Awarded € 1.4 Million Contract Business Wire

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)-- Regulatory News: MEDIAN Technologies (ALMDT.PA), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today ... [Published Yahoo! Finance - Mar 01 2013]

Entities: Median Technologies, Fredrik Brag, Clinical trials, Medical Imaging, Sophia SA

Quotes

...operational strengths in Asia and our commitment to support our customers in this important region," said Fredrik Brag, CEO of MEDIAN Technologies. "We now have a number of ongoing studies in various countries in Asia, and we have a growing installed base of imaging centers using our Lesion Management Solutions (LMS) software for these trials. This is an exciting study and we look forward to developing a long-term partnership with Oxford Oncology" Fredrik Brag added

MEDIAN Technologies selected as imaging solutions provider in phase II NSCLC clinical trial [Published News-Medical.Net - Apr 22 2013]

More Content

sort by: Date \| Relevance
MEDIAN Technologies Awarded Phase II Oncology T... [Published Medicexchange.com - Apr 25 2013]
MEDIAN Technologies selected as imaging solutio... [Published News-Medical.Net - Apr 22 2013]
Un essai clinique de phase II en Asie attribué ... [Published Business Wire Technology News - Apr 17 2013]
MEDIAN Technologies Awarded Phase II Oncology T... [Published Business Wire Technology News - Apr 17 2013]
Un essai clinique de phase II en Asie attribué ... [Published Business Wire Health News - Apr 17 2013]
MEDIAN Technologies Awarded Phase II Oncology T... [Published Business Wire Health News - Apr 17 2013]
Who can you meet at Partnerships in Clinical Tr... [Published Partnerships in Clinical Trials - Apr 01 2013]
MEDIAN Technologies Announces New €633,000 Stud... [Published Yahoo! Finance - Mar 13 2013]
Un nouveau projet de 633 K€ attribué à MEDIAN T... [Published Business Wire Technology News - Mar 13 2013]
MEDIAN Technologies Announces New €633,000 Stud... [Published Business Wire Technology News - Mar 13 2013]
MEDIAN Technologies Announces New €633,000 Stud... [Published Business Wire Health News - Mar 13 2013]
MEDIAN Technologies Awarded € 1.4 Million Contr... [Published Yahoo! Finance - Mar 01 2013]
MEDIAN Technologies Awarded € 1.4 Million Contract [Published EON Health & Medicine - Mar 01 2013]
MEDIAN Technologies Awarded € 1.4 Million Contract [Published Business Wire Health News - Mar 01 2013]